About atai Life Sciences

atai Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders.

We founded atai in 2018 as a response to the significant unmet need and lack of innovation in the mental health treatment landscape, as well as the emergence of therapies that previously may have been overlooked or underused, including psychedelic compounds and digital therapeutics.

Data Provided by Refinitiv. Minimum 15 minutes delayed.


News Releases

SEC Filings

Filing date Form Description

Statement of changes in beneficial ownership of securities